Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lopinavir/Ritonavir”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04276688
What this trial is testing

Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment

Who this might be right for
Novel Coronavirus Infection
The University of Hong Kong 127
Post-approval studies (Phase 4)Ended earlyNCT01068873
What this trial is testing

Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study)

Who this might be right for
HIV Infections
Temple University 1
Post-approval studies (Phase 4)Study completedNCT00931463
What this trial is testing

A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen

Who this might be right for
HIV Infections
Kirby Institute 558
Large-scale testing (Phase 3)Study completedNCT00711009
What this trial is testing

Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)

Who this might be right for
Human Immunodeficiency Virus Infection
Abbott 206
Early research (Phase 1)Ended earlyNCT00044837
What this trial is testing

Hormone Replacement Therapy and Anti-HIV Drugs in HIV-Infected, Postmenopausal Women

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 120
Large-scale testing (Phase 3)Study completedNCT00038636
What this trial is testing

Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors

Who this might be right for
HIV Infections
Abbott 36
Not applicableUnknownNCT00247143
What this trial is testing

High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease

Who this might be right for
HIVAIDS
Lampiris, Harry W., M.D. 20
Post-approval studies (Phase 4)Ended earlyNCT00661349
What this trial is testing

Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in Co-infected HIV/HCV Patients

Who this might be right for
HIV Infections
Germans Trias i Pujol Hospital 9
Early research (Phase 1)Study completedNCT02256826
What this trial is testing

Study of Pharmacokinetic Interaction Between Kaletra® (LPV/r) and BILR 355 BS Plus Ritonavir in Healthy Subjects

Who this might be right for
Healthy
Boehringer Ingelheim 34
Testing effectiveness (Phase 2)Study completedNCT00196625
What this trial is testing

Salvage Therapy With Amprenavir, Lopinavir and Ritonavir in HIV-infected Patients in Virological Failure.

Who this might be right for
HIV Infections
ANRS, Emerging Infectious Diseases 100
Testing effectiveness (Phase 2)UnknownNCT03836833
What this trial is testing

Lopinavir/r/ Lamivudine/ Abacavir as an Easy to Use Paediatric Formulation

Who this might be right for
HIV
Drugs for Neglected Diseases 50
Testing effectiveness (Phase 2)Study completedNCT01296152
What this trial is testing

Pharmacokinetic Interactions Between DMPA and LPV/r Among HIV-Infected Women

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 25
Large-scale testing (Phase 3)UnknownNCT00437684
What this trial is testing

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy

Who this might be right for
HIV InfectionsHepatitis C
IRCCS San Raffaele 50
Post-approval studies (Phase 4)Study completedNCT00869700
What this trial is testing

Pharmacokinetic Interaction Between the Antimalarial Combination Artemether/Lumefantrine and Combination Antiretroviral Therapy Including Lopinavir/Ritonavir in HIV-infected Adults

Who this might be right for
HIV InfectionsMalaria
University of Cape Town 18
Not applicableStudy completedNCT00413153
What this trial is testing

Metabolic Effects of Switching Kaletra to Boosted Reyataz

Who this might be right for
HIV Infections
Massachusetts General Hospital 15
Large-scale testing (Phase 3)Study completedNCT00262522
What this trial is testing

Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, When Coadministered With Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Naive Human Immunodeficiency Virus Type 1 Infected Subjects

Who this might be right for
Human Immunodeficiency Virus Infections
Abbott 664
Post-approval studies (Phase 4)Study completedNCT00145795
What this trial is testing

A Research Study to See if a Change in Therapy for HIV Infection Can Improve the Immune Response to Treatment

Who this might be right for
HIV Infections
University of Chicago 20
Large-scale testing (Phase 3)Ended earlyNCT00443703
What this trial is testing

MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-032)(TERMINATED)

Who this might be right for
HIV Infection
Merck Sharp & Dohme LLC 352
Post-approval studies (Phase 4)Ended earlyNCT00679926
What this trial is testing

Kaletra and Viread in Antiretroviral Naïve Patients

Who this might be right for
HIV Infections
Oklahoma State University Center for Health Sciences 6
Testing effectiveness (Phase 2)WithdrawnNCT00121017
What this trial is testing

A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects

Who this might be right for
HIV InfectionHepatitis C
Abbott 200
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation